Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
GreenBone
GreenBone
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Schenck Process FPM becomes Coperion
Effective August 1, 2024, the company will officially transition its name under Coperion, whilst also providing more resources and broader technology capabilities to customers
Torbay Pharma strengthens leadership team to support North American growth strategy
The company has welcomed Mohammed Nazir as Chief Operating Officer (COO) and Tara Slivey as Chief Product Officer (CPO)
Ingenza expands codABLE gene design algorithm to aid recombinant protein production in yeast
The codABLE platform can help to accelerate the development and production of proteins in yeast hosts
DevPro Biopharma and Bespak complete early studies for novel sustainable albuterol inhaler
The novel formulation exhibits a low global warming potential (GWP) and shows comparable performance to Ventolin HFA
Upcoming event
BIO International Convention Digital
3-6 June, 2024 | Convention | San Diego, US
See all
Related Content
Research & Development
Helsinn Investment Fund leads financial round in GreenBone
New fund backed by the Helsinn Group, focused on supporting early stage opportunities in areas of high unmet patient need
Subscribe now